Lilly Alzheimer's drug an unlikely ace in the hole

NEW YORK (Reuters) - A treatment for Alzheimer's disease is the drug industry's longest shot, and any brave investors willing to place a bet on the outcome are likely to focus on Eli Lilly & Co.

Alzheimer's

Bill Dale wants to talk about his wife, Pat.

Alzheimer’s symptoms often ignored

One out of two people delay seeking help for dementia symptoms a year or more, most often because they shrugged off the memory problems as a normal part of aging.

Alzheimer’s Walk Raises Awareness and Support

Alzheimer’s Walk Raises Awareness and Support

Event aims to teach the warning signs of Alzheimer’s disease

COLUMBIA — Even though Alzheimer’s disease has no cure, there are benefits to knowing if a person has it.

Alzheimer’s walk set for Saturday at Augusta Common

The Alzheimer’s Association’s Augusta chapter is anticipating more than 800 participants at this Saturday’s Walk to End Alzheimer’s — previously known as the Memory Walk.

Health notes: Alzheimer’s care, cancer survivors

New Dawn Memory Care plans to break ground this fall on its first assisted-living location in Arizona.

Drug Shows Promise in Early Alzheimer’s

An experimental drug removed amyloid plaques from the brains of Alzheimer’s disease patients in an early-stage study. Researchers suspect the build-up of such plaques may be a cause of the memory robbing disease

Alzheimer’s or old age?

MANILA, Philippines - Memory loss, confusion, irritability and aggression may be natural signs of aging, but these may also be symptoms of Alzheimer’s disease, a debilitating condition that slowly destroys a person’s ability to carry out the simplest tasks. So how do we know the difference?

Alzheimer attitudes, services in area ‘night and day’ from society’s early days

Donelda Stewart remembers feeling alone and helpless as she watched her mother’s illness get worse and worse. “I didn’t know what to do,” she recalled in an interview. It was the 1980s and Stewart’s mother, Inez, was losing her memory.

Alzheimer’s test developed at Cambridge to be trialled by GPs

Cambridge Cognition, a spin-out of the University, today announced its plans to launch the GP version of their memory test to aid early detection of Alzheimer’s disease.  The company is based on the ground-breaking work of University of Cambridge neuropsychologists Professors Trevor Robbins and Barbara Sahakian who co-invented the original test, the Paired Associates Learning test or PAL.

Alzheimer’s walk raises funds and awareness

The late Ella “Pat” Paul loved yellow roses, the flowers that symbolize joy. It’s an emotion that her daughter continued to provide as Alzheimer’s disease faded her memory.

Alzheimer’s fundraiser will tee off Monday

Alzheimer’s Tennessee Inc.

Alzheimer’s Association to hold Walk to End Alzheimer’s in Florence

FLORENCE — The Alzheimer’s Association is hosting an event on Tuesday, Aug. 23, to kick off Walk to End Alzheimer’s in Florence.  Area residents are invited to drop in at Elmcroft Assisted Living and Memory Care from 6 to 8 p.m

Your Health: Treating Alzheimer’s with a shake

Researchers say a high-powered energy drink could slow Alzheimer’s disease from stealing your memory.

Cells talk more in areas Alzheimer’s hits first, boosting plaque component

Higher levels of cell chatter boost amyloid beta in the brain regions that Alzheimer’s hits first, researchers report.

Alzheimer’s-related protein disrupts motors of cell transport

A protein associated with Alzheimer’s disease clogs several motors of the cell transport machinery critical for normal cell division, leading to defective neurons that may contribute to the memory-robbing disease, University of South Florida researchers report.

New Alzheimer’s guidelines redefine disease

Guidelines for diagnosing Alzheimer’s — the memory-stealing disease — have been updated for the first time in 27 years.

Local Alzheimer’s support group forms

Alzheimer’s disease has been called a cruel medical condition, and rightly so.

Burgess introduces MIND Act to establish Alzheimer’s research bonds

When President Reagan announced that he had Alzheimer’s Disease, four million Americans suffered from the disease. Today, that number has grown to 5.4 million, and it is projected to afflict 10 million baby boomers.